{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-171530","form_type":"8-K","ticker":"VCNX","cik":"0001205922","company_name":"VACCINEX, INC.","filed_at":"2022-06-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:59.964368+00:00","generated_at":"2026-06-25T02:38:48.822253+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"low","headline":"Vaccinex presents at Jefferies conference on KEYNOTE-B84 study; no new data disclosed","bullets":["Presented at Jefferies Healthcare Conference on June 10, 2022 at 10:30 a.m. ET.","Presentation covered the KEYNOTE-B84 study of pepinemab (anti-SEMA4D) in HNSCC.","Filing does not include any new clinical data or financial results.","Corporate slide deck furnished as Exhibit 99.1, available on company website."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-171530","json":"https://secwatch.observer/filing/0001193125-22-171530.json","markdown":"https://secwatch.observer/filing/0001193125-22-171530.md","text":"https://secwatch.observer/filing/0001193125-22-171530.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1205922/000119312522171530/0001193125-22-171530-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1205922/000119312522171530/d314833d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T02:38:48.822253+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}